What’s Driving Growth in the Bacterial Vaginosis Market? Insights into Key Trends and Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the bacterial vaginosis market grown in recent years?
In recent times, the market size for bacterial vaginosis has witnessed substantial growth. It is projected to expand from $3.03 billion in 2024 to $3.32 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.7%. This growth during the historical period is a result of factors like the rising adoption of point-of-care diagnostics, the surge in e-commerce, an increase in precarious sexual behaviors, an uptick in STI vaccinations, and widened access to healthcare.
How is the bacterial vaginosis market size expected to evolve during the forecast period?
The market size for bacterial vaginosis is anticipated to experience robust expansion in the upcoming years, reaching $4.75 billion in 2029 with a compound annual growth rate (CAGR) of 9.4%. The escalation during the forecast period can be associated with the growing occurrence of bacterial vaginosis, the surge in demand for functional foods, the increasing incidence of sexually transmitted infections (STIs), escalating women’s health conditions prevalence, and increased menopause awareness. Foreseen trends for the forecast period encompass the utilization of artificial intelligence (AI) in diagnoses, the adoption of probiotics, advances in STI testing at home, and the use of sustainable materials in women’s health devices.
Get your bacterial vaginosis market report here!
https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report
Which key drivers are propelling the bacterial vaginosis market’s growth?
The escalating prevalence of sexually transmitted infections (STIs) is poised to propel the expansion of the bacterial vaginosis market. STIs encompass infections predominantly passed on through sexual interaction, caused by bacteria, viruses or parasites. The heightened prevalence of these infections is attributable to unprotected sex, a multitude of partners, lack of cognizance, and antibiotic resistance. The prevalence of bacterial vaginosis, which disrupts the vaginal bacterial harmony, augments the likelihood of infections like HIV and chlamydia. In an instance, the European Centre for Disease Prevention and Control (ECDC), seated in Sweden, reported a significant leap in reported cases in 2022 compared to the prior year, with gonorrhea swelling by 48%, syphilis by 34%, and chlamydia by 16% as of March 2024. As such, the surging prevalence of STIs is underpinning the progression of the bacterial vaginosis market.
What are the market segments in the bacterial vaginosis industry?
The bacterial vaginosis market covered in this report is segmented –
1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types
2) By Product: Below 15 Years, Between 15-45, Other Products
3) By Application: Antibiotics, Other Applications
4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays
2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing
3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp
Which leading companies are shaping the growth of the bacterial vaginosis market?
Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories
What key trends are currently impacting the bacterial vaginosis market’s development?
The bacterial vaginosis market is experiencing a boost as dominant companies prioritize developing innovative solutions like multiplexed polymerase chain reaction (PCR) tests, intending to hasten diagnosis and treatment procedures. Multiplexed PCR tests have the ability to simultaneously amplify and detect numerous target DNA or RNA sequences within a singular PCR experiment. For example, Cepheid, a biotechnology research firm based in the U.S., launched the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This panel can provide results within an hour and efficiently detects three types of vaginal infections – bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) – from just a single sample. The system is adaptable to both clinician-acquired and self-acquired swabs, maximizing the diagnostic precision and advancing treatment outcomes for women using automated real-time PCR technology. Its applicability in various clinical environments ensures effective and accurate identification of vaginal infections.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21110
Which geographic areas are influencing the growth of the bacterial vaginosis market?
North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Anemia and Other Blood Disorder Drugs Global Market Report 2025
Blood Cancer Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
Proton Pump Inhibitors Global Market Report 2025
https://thebusinessresearchcompany.com/report/proton-pump-inhibitors-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
